Literature DB >> 2472309

Transferrin and transferrin receptor expression in intraocular proliferative disease. APAAP-immunolabeling of retinal membranes and ELISA for vitreal transferrin.

M Weller1, P Wiedemann, H Moter, K Heimann.   

Abstract

Transferrin (TF) is the major transport protein involved in human iron metabolism. The expression of the cell-surface TF receptor is associated with cellular proliferation, the dominant feature of proliferative vitreoretinal disorders with traction retinal detachment. A total of 14 retinal membranes from patients with different clinical diagnoses contained immunoreactive TF. Expression of the cell-surface TF receptor was confirmed by a monoclonal anti-human TF-receptor antibody label in 11 of the 14 specimens. We developed a noncompetitive enzyme-linked immunosorbent assay (ELISA) for TF and found it to be a significant component of vitreal protein, with a level of 65.7 +/- 33.9 mg/l. Vitreal TF as a major iron acceptor probably has a protective function, but its interaction with macrophages and its growth-promoting activity may subsequently stimulate the proliferation of fibroblasts and retinal pigment epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472309     DOI: 10.1007/bf02172763

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  34 in total

1.  Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies.

Authors:  J F Lesley; R J Schulte
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

2.  Experimental epiretinal proliferation induced by intravitreal red blood cells.

Authors:  B Miller; H Miller; S J Ryan
Journal:  Am J Ophthalmol       Date:  1986-08-15       Impact factor: 5.258

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Are usual immunochemical methods for the determination of human serum transferrin influenced by the iron-saturation of the protein?

Authors:  M Vernet-Nyssen; M Paris; M O Benoit; G Plomteux
Journal:  Clin Chim Acta       Date:  1984-11-30       Impact factor: 3.786

5.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

6.  Comparative studies of the binding and growth-supportive ability of mammalian transferrins in human cells.

Authors:  R C Penhallow; A Brown-Mason; R C Woodworth
Journal:  J Cell Physiol       Date:  1986-08       Impact factor: 6.384

7.  Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy.

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  Int Ophthalmol       Date:  1988-01       Impact factor: 2.031

8.  Inflammation-induced changes in the iron concentration and total iron-binding capacity of the intraocular fluids of rabbits.

Authors:  M C McGahan; L N Fleisher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

9.  Cell proliferation and expression of the transferrin receptor gene: promoter sequence homologies and protein interactions.

Authors:  W K Miskimins; A McClelland; M P Roberts; F H Ruddle
Journal:  J Cell Biol       Date:  1986-11       Impact factor: 10.539

10.  Platelet-derived growth factor in chemotactic for fibroblasts.

Authors:  H Seppä; G Grotendorst; S Seppä; E Schiffmann; G R Martin
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  8 in total

1.  Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.

Authors:  M Weller; R Clausen; M Bresgen; K Heimann; P Wiedemann
Journal:  Int Ophthalmol       Date:  1990-07       Impact factor: 2.031

Review 2.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

3.  An immunochemical quantitative analysis of the protein pattern in physiologic and pathologic vitreous.

Authors:  R Clausen; M Weller; P Wiedemann; K Heimann; R D Hilgers; K Zilles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

Review 4.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

5.  Vitronectin and proliferative intraocular disorders. II. Expression of cell surface receptors for fibronectin and vitronectin in periretinal membranes.

Authors:  M Weller; P Wiedemann; M Bresgen; K Heimann
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

6.  Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy.

Authors:  A J Augustin; W Breipohl; T Böker; J Lutz; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

7.  Increased lipid peroxide level and myeloperoxidase activity in the vitreous of patients suffering from proliferative vitreoretinopathy.

Authors:  T Böker; A J Augustin; W Breipohl; M Spitznas; J Lutz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-11       Impact factor: 3.117

Review 8.  Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?

Authors:  Andreea Ciudin; Cristina Hernández; Rafael Simó
Journal:  Exp Diabetes Res       Date:  2010-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.